Beckman Coulter has identified that the reagent lot identified above was inadvertently released to market despite not meeting its full product specification. The HLA-B27 Median Fluorescence Intensity (MDFI) of this lot is higher than lots meeting the product specification, which may lead to: (1) an indicated result in the indeterminate zone when the true result is in the negative range, or (2) an indicated result in the positive range when the true result is in the indeterminate zone. The issue was discovered on 2016, March 21 during periodic review of our batch records. There has been no report of death or injury related to this defect.